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Abstract
Recombinant tissue plasminogen activator
(rTPA) is one of the main portions of acute
ischemic stroke management, but unfortu-
nately has some complications. Myocardial
infarction (MI) is a hazardous complication of
administration of intravenous rTPA that has
been reported recently. A 78-year-old lady was
admitted for elective coronary artery bypass
graft surgery. On the second day of admission,
she developed acute left hemiparesis and
intravenous rTPA was administered within 120
minutes. Three hours later, she has had chest
pain. Rescue percutaneous coronary interven-
tion was performed on right coronary artery
due to diagnosis of inferior MI, and the symp-
toms were resolved.
Introduction
The introduction of intravenous alteplase,
which is a recombinant tissue plasminogen
activator (rTPA) for reperfusion therapy, has
led to a dramatic change in approach to
patients with ischemic stroke. The intra-
venous route of this medication should be
used in acute phase of ischemic stroke,
notably within 4.5 hours of initiation of ictus.1
The typical method for administration of intra-
venous alteplase is the total dosage of 0.9 mg
per kilogram of body weight (maximum 90
mg) that one tenth of total dosage is adminis-
tered as a bolus dose and the remaining 90% of
total dosage is infused over the next hour.2
However, administration of rTPA had some
hazardous dangers. There are some risks of
major bleeding, particularly in the brain; there-
for, patients need to be carefully selected based
on eligible criteria. Hypersensitivity reaction
including angioedema, reocclusion and sec-
ondary embolization and brain edema due to
reperfusion injury are the other reported com-
plications of rTPA administration in ischemic
stroke.3
Cardiac complications following acute cere-
brovascular accidents are common, but fortu-
nately many of them had minimal cardiac
adverse effects.4,5 Up to 12% of acute cere-
brovascular accidents (CVAs) may be associat-
ed with acute myocardial infarction within 72
hours of onset.4,6 There are some possible
explanation, but the clear cause is still
unknown. There may be an underlying cardiac
embolic source for both ischemic stroke and
acute myocardial infarction such as a left ven-
tricular thrombus.7 Embolic stroke to insula
can cause autonomic dysfunction and cardiac
arrhythmia which can cause ischemia of
myocardium due to increasing demand of pre-
morbid coronary arteries.8 Several conditions
such as aortic dissection, large vessel arteritis
and endocarditis can induce myocardial infarc-
tion and ischemic stroke, simultaneously.9,10 In
addition, some drugs like amphetamines and
cocaine may lead to concurrent occurrence of
myocardial infarction and ischemic stroke.11
An indication of acute myocardial infarction
after administration of rTPA for ischemic
stroke is increasingly reported.7,9,10 In this
study, we described a patient with previous
cardiovascular risk factors who was complicat-
ed with acute myocardial infarction following
prescription of rTPA for an acute ischemic
stroke.
Case Report
A 78-year-old right-handed lady was referred
to elective cardiac surgery department for
coronary artery bypass graft (CABG) surgery.
She was hospitalized for conducting the pre-
operation investigations. On the second day of
admission, she developed sudden onset weak-
ness of left upper and lower limbs and drop-
ping of left side of the face. She has had a past
history of hypertension, which was controlled
by taking 50 mg atenolol twice a day. She has
had angina pectoris but not any history of
myocardial infarction. According to her coro-
nary angiography, she was candidate for CABG
surgery due to coronary artery stenosis.
The vital signs at the onset of left side hemi-
paresis included pulse rate of 74/min with reg-
ular rhythm, respiratory rate of 16/min, blood
pressure of 160/100 mm Hg and normal body
temperature. Her baseline electrocardiogram
showed evidences of left ventricular hypertro-
phy (LVH) and there was no evidence of acute
cardiac ischemia. 
Axial brain computed tomography (CT) scan
without contrast, which has been done after 30
minutes of hemiparesis, showed no evidence
of hemorrhage, no new parenchymal hypoden-
sity and no dense clot sign. Although, the brain
CT scan showed an old stroke in left hemi-
sphere which was not compatible with the
symptoms of the patient. Due to acute left
hemiparesis and no evidence of hemorrhage
on brain CT scan, the diagnosis of ischemic
stroke with unclear mechanism was made. The
National Institutes of Health Stroke Scale
(NIHSS) was 10 out of 42, composed of 2 score
for partial paralysis of lower face, 3 score for
left arm motor weakness, 3 score for left leg
motor weakness, 1 score for sensory distur-
bances and 1 score for language problem. Next
decision was to administer the intravenous
thrombolytic. Intravenous rTPA was started
after 120 minutes of the event onset. The bolus
dosage of rTPA was 8 mg, followed by infusion
of 58 mg in the next 60 minutes.
Approximately three hours later, the patient
complained of chest pain and palpitation. The
immediate electrocardiogram (ECG) showed
ST-segment elevations in the inferior leads (II,
III, aVF), and ST-segment depressions in the
anterolateral leads (I, aVL) (Figure 1). The
patient was emergently transferred to the car-
diac catheterization laboratory for rescue per-
cutaneous coronary intervention (PCI). On
angiography, the occlusion of right coronary
artery was detected. Thrombectomy via an
aspiration catheter was performed and normal
coronary blood flow was restored. Then PCI
was conducted on right coronary artery and
posterior descending artery bifurcation with
two bare metal stents. After revascularization,
the patient’s heart rhythm returned to normal
sinus and hypotension was resolved. The brain
CT scan was repeated and showed a new hypo-
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density in right parietal lobe. Brain MRI with
diffusion-weighted sequence (DW) revealed a
watershed ischemic infarction between anteri-
or cerebral artery (ACA)-multiple correspon-
dence analysis (MCA) and MCA-principal com-
ponent analysis (PCA) territories in right side,
which was hyposignal in equivalent Apparent
Diffusion Coefficient (ADC) sequence that
means an acute stroke occurred (Figure 2).
The echocardiography revealed a left-ventricu-
lar ejection fraction of 50% with inferior
hypokinesia and without evidence of intracar-
diac thrombus or intracardiac right-to-left
shunt. 
Discussion
In this case, the development of MI related
to the use of IV rTPA within 24 hours after
receiving of IV rTPA was presented. Despite
having previous major involvement of coronary
arteries, the patient had not any symptoms of
acute myocardial infarction before admission
and during the first day of admission. Sudden
occurrence of acute left hemiparesis in our
patient may have some possible mechanisms;
first, the coronary artery disease may be asso-
ciated with diffuse atherosclerosis, which
involved carotid artery simultaneously. The
other possible explanation is an embolus orig-
inating from the morbid heart or a plaque of
aorta. In fact, the both of thrombotic or embolic
mechanism for ischemic stroke may be the
presumed mechanism, but the evidence of an
old stroke in left hemisphere and now inci-
dence of another stroke in left hemisphere sig-
nifies the embolic mechanism compared to
thrombotic mechanism.
Our patient developed a myocardial infarc-
tion in right heart after administration of
rTPA. One can suppose that there was a car-
diac clot, which was the mechanism of
ischemic stroke and itself introduced an extra
embolus to right coronary artery after the
injection of rTPA. The presence of cardiac clot
during ischemic stroke can be 10 to 15% based
on the used modality including trans-
esophageal echocardiography.12,13 In fact rTPA
can degrade the clot to small fragments with
subsequent embolization to coronary arteries
leading to MI.9
The presented patient afflicted with an infe-
rior MI after administration of rTPA. In the
cases that presented with Stewa et al.9 and
Wallace et al.,7 also the patients developed an
inferior MI following administration of rTPA. It
is not clear if there is any direct correlation
between rTPA injection and occurrence of infe-
rior MI, or maybe there is an identical etiology
for both of ischemic stroke and inferior MI, as
we encounter in aortic dissection. Contraries,
there are some evidences for development of
ischemic stroke as a consequence of inferior
MI.14,15 In addition to common cause of
ischemic stroke after any types of MI, the infe-
rior MI has some special characteristics which
are risk factors for ischemic stroke. Inferior MI
can lead to infarction of right ventricle in
about half of the cases, which is associated
with severe hemodynamic compromise and
diminished cardiac output.14 Hemodynamic
compromise decrease cerebral perfusion espe-
cially in premorbid vessels and lead to stroke.
It is also shown that inferior MI can be compli-
cated with transient atrial fibrillation and
future risk of ischemic stroke in preserve of
ejection fraction will increased.15
Conclusions
Nowadays rTPA is widely used for the treat-
ment of acute stoke. The occurrence of MI
especially inferior MI had been reported fol-
lowing administration of rTPA but current data
cannot clarify the underlying reason. It is a
hazardous complication that needs to be care-
fully considered after administration of rTPA
and should be treated quickly. 
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